COPD

Exploring the Use of Omics to Eliminate Sex and Gender Differences in COPD

By

Tori Rodriguez, MA, LPC, AHC

Although it has become widely accepted that COPD encompasses a range of phenotypes, the development of a precision medicine approach has been slow.

Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve Quality of Life

By

Amit Akirov, MD

Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.

Assessing Exercise Techniques in Pulmonary Rehabilitation for COPD

By

Tori Rodriguez, MA, LPC, AHC

Pulmonary rehabilitation programs represent a key component in the management of patients with chronic obstructive pulmonary disease.

Effect of Air Pollution on Inflammation, Coagulation in Patients With AECOPD

By

Sheila Jacobs

To what extent do daily air pollution levels contribute to acute exacerbations of COPD?

The Role of Peripheral Eosinophil Counts in Identifying COPD Subtype

By

Brandon May

Researchers analyzed elevated FeNO levels and peripheral eosinophil counts to determine the prevalence of eosinophilic inflammation in patients with COPD.

Dedicated Inhaler Technique Reduces Exacerbations in COPD and Asthma

By

Sheila Jacobs

Does teaching proper technique for inhaler use to COPD and asthma patients measurably affect their health outcomes?

AECOPD Associated With Increased High-Sensitivity Cardiac Troponin T

By

Brandon May

New study results indicate that reducing systemic inflammation should be an important focus of COPD management.

High-Flow Nasal Cannula Oxygen Therapy in COPD

By

Bryant Moeller

A new meta-analysis tested the theory that HFNC therapy for COPD can decrease PaCO2 and transcutaneous PaCO2 and increase PaO2 and 6-minute walking distance.